GERSHWIN T BLYDEN

Allopathic & Osteopathic Physicians|Internal Medicine MIAMI, FL NPI 1851344014

General Payments — all program years on this page

$8,763.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 151
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,284.17 across 35 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $1,501.993
Long term medical supply or device loan $1,065.4412
Food and Beverage $716.7420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CSL Behring $1,771.996
NOVARTIS PHARMACEUTICALS CORPORATION $1,083.6113
Janssen Biotech, Inc. $205.547
Acerta Pharma LLC $177.987
Agios Pharmaceuticals, Inc. $45.052

By program year

Program yearAmountRecords
2018 $533.9324
2019 $308.2117
2020 $158.758
2021 $271.5112
2022 $2,833.7528
2023 $1,373.6727
2024 $3,284.1735

Records — PY2024 (35)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078443614 Janssen Biotech, Inc. $20.40 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078445244 Janssen Biotech, Inc. $23.34 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078446217 Janssen Biotech, Inc. $27.20 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078450836 Janssen Biotech, Inc. $36.00 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078451039 Janssen Biotech, Inc. $30.40 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078452416 Janssen Biotech, Inc. $33.20 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078452431 Janssen Biotech, Inc. $35.00 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086616663 Novartis Pharmaceuticals Corporation $83.33 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616665 Novartis Pharmaceuticals Corporation $83.33 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616667 Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616671 Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616675 Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616679 Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616681 Novartis Pharmaceuticals Corporation $83.33 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616683 Novartis Pharmaceuticals Corporation $83.33 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616685 Novartis Pharmaceuticals Corporation $83.33 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616687 Novartis Pharmaceuticals Corporation $83.33 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086616689 Novartis Pharmaceuticals Corporation $83.33 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086779021 Novartis Pharmaceuticals Corporation $18.17 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086779023 Novartis Pharmaceuticals Corporation $83.33 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1104202337 AstraZeneca Pharmaceuticals LP $24.53 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104231425 AstraZeneca Pharmaceuticals LP $28.75 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104494662 AstraZeneca Pharmaceuticals LP $27.66 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104696656 AstraZeneca Pharmaceuticals LP $18.66 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104763372 AstraZeneca Pharmaceuticals LP $25.44 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105604441 AstraZeneca Pharmaceuticals LP $24.61 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105791030 AstraZeneca Pharmaceuticals LP $28.33 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134619785 CSL Behring $692.62 12/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1134619787 CSL Behring $218.85 12/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1134619789 CSL Behring $125.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134619791 CSL Behring $60.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134619793 CSL Behring $85.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134619795 CSL Behring $590.52 12/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149641322 Agios Pharmaceuticals, Inc. $23.83 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149642850 Agios Pharmaceuticals, Inc. $21.22 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.